Saturday, February 17, 2018

UPDATE 1-AstraZeneca's immunotherapy drug wins key lung cancer approval

* Rival BMS, Merck, Roche drugs approved for later disease (Adds details on competition, size of market opportunity)
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)